News

Dr. Brian O’Rourke, CADTH President and Chief Executive Officer, is pleased to announce the appointment of four new members and a new chair to Canadian Drug Expert Committee (CDEC), and two new members and a new chair to its Health Technology Expert Review Panel (HTERP). Canadian Drug Expert…
See CDR Update 128 for important news and information regarding the CADTH Common Drug Review.
CADTH is pleased to announce the 2018 CADTH Symposium Travel Award Program for students and patient group representatives. Eligible students and patient group representatives can receive up to $2,000 to offset registration, travel, food, accommodation, and other conference-related expenses. Travel…
Dr. Hakique Virani Medical Director, Metro City Medical Clinic; and Assistant Clinical Professor, Department of Medicine, University of Alberta There is no one face of Canada’s drug poisoning crisis— it affects all of us. Families and communities continue to be devastated by the loss of loved ones…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
Event Date: October 3, 2017Location: Beanfield Centre, Room 204 ABC 105 Princes’ Blvd., Toronto, ON The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on our drug portfolio, including CADTH’s Common Drug Review (CDR), pan-Canadian Oncology Drug Review (pCODR), and…
CADTH has completed its Therapeutic Review update of second-line therapies for patients with type 2 diabetes. The following reports are now available on the CADTH website: final science report on second-line therapy (clinical and economic evaluations) final recommendations report on second-line…
Delivering on our commitment to provide evidence and resources that support Canada’s response to the opioid crisis continues to be a key priority for CADTH. Over the summer we’ve answered a range of research questions related to the treatment of opioid use disorder and the use of drug and non-drug…
The 2018 CADTH Symposium will be held in Halifax, Nova Scotia from April 15 to 17, 2018. The theme is Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care. Submission Deadline: Friday, October 27, 2017. Questions may be sent by email to [email protected].  
A draft report on Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update 2017-08-22 2017-09-06…
A draft report on Dental Amalgams Compared With Resin Composites is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Dental Amalgams Compared With Resin Composites 2017-08-21 2017-09-05 Consultation Document Product Type Submit Stakeholder…
CADTH is pleased to announce the election of four new members to its Board of Directors effective July 11, 2017: John Abbott, Jurisdictional (Atlantic Provinces) Mitch Moneo, Jurisdictional (Western Provinces) Ellen Pekilis, Public Dr. Charmaine Roye, Health System. The CADTH Board of Directors has…